HIV aspartyl protease inhibitors as promising compounds against Candida albicans André Luis Souza dos Santos

Figure 3 Different roles performed by C. albicans Saps in vital biological processes as well as during the different steps of interaction with host structures. Both physiological and pathological processes are inhibited (red lines) in different extensions, depending on HIV protease inhibitors (PIs), except for the yeast to mycelia transformation (differentiation) where conflicting results were observed (dotted red line).